Open access
Sep 2026
Cardiovascular Outcomes With Potassium Binders in Patients with Heart Failure and Hyperkalemia.
BACKGROUND AND AIMS Hyperkalaemia complicates heart failure (HF) and may limit guideline-directed therapy. Potassium binders differ in pharmacologic properties and sodium load, raising cardiovascular safety concerns. This study compared cardiovascular outcomes associated with patiromer, sodium zirconium cyclosilicate (...
L. Fauchier, Mickael Guglieri, T. Lenormand et al.
· ESC Heart Failure · 0 citations